Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02605863
Title Enzalutamide for Bladder Cancer Chemoprevention
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Rochester
Indications

urinary bladder cancer

Therapies

Enzalutamide

Age Groups: adult
Covered Countries USA


No variant requirements are available.